We used a tractable model of blood cancer driven by a retroviral construct encoding the human MLL-ENL leukemogenic oncoprotein fused to GFP (Schoch et al, 2003; Zuber et al, 2009) (Fig. 4A). Here, KMT2A is linked to hematopoietic and lymphoid system neoplasm.